An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®
Stopped Business Decision; Insufficient Enrollment
Conditions
- Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
Sponsor
Ariad Pharmaceuticals
Collaborators